Biotechnology in the US
The Biotechnology industry is growing quickly, with revenue increases over the past five years driven by rising use of ethanol, demand for improved crop yields and the increasing medical needs of an aging population. Although the industry has grown, a consolidation trend has emerged as large pharmaceutical makers have increasingly targeted industry firms for acquisition, to expand their product portfolios ahead of impending patent expirations. Continued spending on research and development, including by the federal government, will benefit the industry in the next five years, driving growth in both revenue and profit.
Companies in this industry primarily use living organisms or molecular and cellular techniques to provide chemicals, food and services that meet human needs. The industry excludes companies primarily involved in developing small-molecule pharmaceuticals, performing contract research or manufacturing biological equipment.
This report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry key players and their market shares.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook